Cromolyn Sodium Inhalation Solution
Cromolyn Sodium Inhalation Solution, 20 mg/2 mL
Approved
Approval ID
0209cd6c-5c43-0b93-e063-6294a90ac964
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 9, 2023
Manufacturers
FDA
Ritedose Pharmaceuticals, LLC
DUNS: 968062294
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cromolyn Sodium Inhalation Solution
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code76204-028
Application NumberANDA209453
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cromolyn Sodium Inhalation Solution
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateAugust 9, 2023
FDA Product Classification
INGREDIENTS (2)
CROMOLYN SODIUMActive
Quantity: 20 mg in 2 mL
Code: Q2WXR1I0PK
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT